Steven E. Kahn

Research interests

Publications

• Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

  Nature Medicine · 2024 · https://doi.org/10.1038/s41591-024-03015-5

• Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

  The Lancet · 2024 · https://doi.org/10.1016/s0140-6736(24)01498-3

• Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2307563

• Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)02188-7

• Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes

  JAMA · 2019 · https://doi.org/10.1001/jama.2019.13772

• Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

  Diabetes Care · 2019 · https://doi.org/10.2337/dc18-1970

• Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)

  Diabetes Care · 2019 · https://doi.org/10.2337/dc19-0244

• Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)

  Diabetes Care · 2019 · https://doi.org/10.2337/dc19-0244

• Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

  JAMA · 2018 · https://doi.org/10.1001/jama.2018.18269

• Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

  The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(13)62154-6

• Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?

  The Journal of Clinical Endocrinology & Metabolism · 2011 · https://doi.org/10.1210/jc.2011-0585

• Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?

  Diabetes Care · 2011 · https://doi.org/10.2337/dc11-0447

• Updated Genetic Score Based on 34 Confirmed Type 2 Diabetes Loci Is Associated With Diabetes Incidence and Regression to Normoglycemia in the Diabetes Prevention Program

  Diabetes · 2011 · https://doi.org/10.2337/db10-1119

• Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

  Nature Immunology · 2010 · https://doi.org/10.1038/ni.1935

• Differential Effects of Abdominal Adipose Tissue Distribution on Insulin Sensitivity in Black and White South African Women

  Obesity · 2009 · https://doi.org/10.1038/oby.2009.73

• The prevention of type 2 diabetes

  Nature Clinical Practice Endocrinology &#38 Metabolism · 2008 · https://doi.org/10.1038/ncpendmet0843

• Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity

  Journal of Biological Chemistry · 2004 · https://doi.org/10.1074/jbc.m311113200

• The effect of intensive endurance exercise training on body fat distribution in young and older men

  Metabolism · 1991 · https://doi.org/10.1016/0026-0495(91)90239-s

Current projects

No projects listed.